Hillary Clinton's Plan to Reduce Unjustified Drug Prices Hikes Hits Pharma Stocks
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
Rumors Abound on Mylan (MYL) After Conference Cancellation
September 2, 2016 9:48 AM EDTThere are a lot of rumors floating around Mylan (NASDAQ: MYL) after the company was said to pull form a Morgan Stanley conference. One rumors is the CEO is going to leave.
Shares are down 2.2% early following Hillary Clinton outline on curbing drug price hikes.
... More